Adherence to Mammography Screening Guidelines Among Transgender Persons and Sexual Minority Women

Bazzi, Angela R.; Whorms, Debra S.; King, Dana; Potter, Jennifer

doi:10.2105/ajph.2015.302851

Cited by 87 publications

(45 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Yet, the use of mammography in transgender individuals has not been adequately studied. Importantly, one retrospective study of transgender individuals at a community health center in Massachusetts showed that transgender individuals were not as likely as cisgender patients to follow guidelines of mammography screening [16]. Maglione et al analyzed 8 existing cases and described two original cases (65-year-old and a 55-year-old that had a family history of breast cancer) of MtF transgender individuals who developed breast cancer, reporting that breast cancer occurs at a younger age and is more often ER (estrogen receptor) positive compared to males [5].…”

Section: Discussionmentioning

confidence: 99%

Breast Cancer Suspicion in a Transgender Male-to-Female Patient on Hormone Replacement Therapy Presenting with Right Breast Mass: Breast Cancer Risk Assessment and Presentation of a Rare Lesion

Tongson

Konovalova

Dhawan

et al. 2017

Case Reports in Oncological Medicine

View full text Add to dashboard Cite

There has been an increasing use of hormonal therapy among male-to-female (MtF) transgender individuals. This long-term hormone replacement therapy (HRT) renders MtF individuals a unique patient subgroup in terms of breast cancer risk. This case describes a MtF transgender who presented with a breast lesion concerning for malignancy following hormonal replacement therapy. The patient additionally had a strong family history of breast cancer. Final pathology revealed lobular hyperplasia in the setting of gynecomastia and pseudoangiomatous stromal hyperplasia (PASH). Both pathology findings are rare in biological females, let alone in the setting of hormone replacement therapy in a MtF individual. While the number of reported cases of suspicious breast lesions in this population remains scarce, it presents both a diagnostic and therapeutic challenge due to the nature of the treatment course and the lack of research in this recently growing subgroup of patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Breast Cancer Suspicion in a Transgender Male-to-Female Patient on Hormone Replacement Therapy Presenting with Right Breast Mass: Breast Cancer Risk Assessment and Presentation of a Rare Lesion

Tongson

Konovalova

Dhawan

et al. 2017

Case Reports in Oncological Medicine

View full text Add to dashboard Cite

show abstract

“…A recent evaluation of medical records from a community health center that provides care to underserved populations, including gender and sexual minorities, examined adherence to mammography screening guidelines. Adherence was defined as having 1 or more mammograms during the preceding 2-year interval (109). Among nontransgender females included in the study, 73% were considered screening adherent.…”

Section: Other Cancer Risk Factorsmentioning

confidence: 99%

Cancer in Transgender People: Evidence and Methodological Considerations

Braun

Nash

Tangpricha

et al. 2017

Epidemiologic Reviews

167

122

View full text Add to dashboard Cite

Transgender people comprise a diverse group of individuals whose gender identity or expression differs from that originally assigned to them at birth. Some, but not all, transgender people elect to undergo medical gender affirmation, which may include therapy with cross-sex hormones and/or surgical change of the genitalia and other sex characteristics. As cross-sex hormones administered for the purposes of gender affirmation may be delivered at high doses and over a period of decades, the carcinogenicity of hormonal therapy in transgender people is an area of considerable concern. In addition, concerns about cancer risk in transgender patients have been linked to sexually transmitted infections, increased exposure to well-known risk factors such as smoking and alcohol use, and the lack of adequate access to screening. Several publications have identified cancer as an important priority in transgender health research and called for large-scale studies. The goals of this article are to summarize the evidence on factors that may differentially affect cancer risk in transgender people, assess the relevant cancer surveillance and epidemiologic data available to date, and offer an overview of possible methodological considerations for future studies investigating cancer incidence and mortality in this population.

show abstract

“…54–58 Extant literature demonstrates that sexual minority women underutilize cervical cancer screening services. Screening rates are estimated to be between 43 – 71% compared to 73% in the general female population.…”

Section: Disparities In Unmet Medical Needs By Sexual Orientationmentioning

confidence: 99%

Addressing Health Care Disparities Among Sexual Minorities

Baptiste-Roberts

Oranuba

Werts

et al. 2017

Obstetrics and Gynecology Clinics of North America

110

View full text Add to dashboard Cite

Synopsis Despite the paucity of population-based research on the health status and health needs of lesbian, gay, bisexual and transgender (LGBT) individuals, there is evidence of health disparities between sexual minority and heterosexual populations. Although the focus of LGBT health research has been HIV/AIDS and sexually transmitted infection among men who have sex with men, there is some documentation of health disparities among sexual minority women, with sexual minority women reporting poorer mental and physical health, in addition to less access to and less health care utilization. Using the minority stress framework, these disparities may be due in part to individual prejudice, social stigma and discrimination. To ensure equitable health for all, there is urgent need for targeted culturally sensitive health promotion, cultural sensitivity training for healthcare providers and intervention focused research.

show abstract

Adherence to Mammography Screening Guidelines Among Transgender Persons and Sexual Minority Women

Cited by 87 publications

References 15 publications

Breast Cancer Suspicion in a Transgender Male-to-Female Patient on Hormone Replacement Therapy Presenting with Right Breast Mass: Breast Cancer Risk Assessment and Presentation of a Rare Lesion

Breast Cancer Suspicion in a Transgender Male-to-Female Patient on Hormone Replacement Therapy Presenting with Right Breast Mass: Breast Cancer Risk Assessment and Presentation of a Rare Lesion

Cancer in Transgender People: Evidence and Methodological Considerations

Addressing Health Care Disparities Among Sexual Minorities

Contact Info

Product

Resources

About